Q14
Analytical Procedure Development
Current edition
Step 4, 1 November 2023
Current edition
Step 4, 1 November 2023
About this standard
Harmonizes the scientific approach to developing analytical procedures and sets principles for describing the development process. It aims to improve communication between industry and regulators and support risk-based post-approval change management.
Recognition by market
Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts
- European UnionImplemented
- Edition accepted
- -
- National code
- EMA/CHMP/ICH/195040/2022
Effective June 14, 2024
- JapanImplemented
- Edition accepted
- -
- National code
- PSB/ PED Notification No. 1009-2
Effective October 9, 2025
- ChinaImplemented
- Edition accepted
- -
- National code
- NMPA, China Announcement No.65(2024)
Effective November 24, 2024
- South KoreaNot yet implemented
- Edition accepted
- -
- National code
- -
Implementation is in progress. Date listed: 1 December 2027.
- SwitzerlandImplemented
- Edition accepted
- -
- National code
- -
Effective November 1, 2023. ICH guidelines apply in Switzerland automatically once they reach Step 4.
- Saudi ArabiaNot yet implemented
- Edition accepted
- -
- National code
- -
Not yet implemented by this regulator.
Testing requirements that cite it
Open the market page and its pathway pages for the full requirement, protocol and report content
Japan
- Validation of analytical methodsAnalytical method validation · Not stated
Related standards: FDA analytical procedures guidance, Q2(R2), USP <1224>, USP <1225>, USP <1226>, USP <621>, M10, ASEAN analytical validation guideline, RDC 166/2017, Taiwan analytical validation manual. See all standards.